Paolo Bosetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Paolo Bosetti has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Simon Cauchemez
Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, INSERM U1332, CNRS UMR 2000, Paris, France
4 shared publications - Vittoria Colizza
Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (IPLESP), Paris, France
4 shared publications - Lulla Opatowski
Epidemiology and Modelling of Bacterial Escape to Antimicrobials (EMEA), Institut Pasteur, Université Paris Cité, Paris, France
2 shared publications - Abhishek Dasgupta
Oxford Research Software Engineering Group, Doctoral Training Centre Oxford University of Oxford
1 shared publication - Aine O'Toole
Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK
1 shared publication - Alexander Eugene Zarebski
The School of Mathematics and Statistics, The University of Melbourne, Parkville, VIC, Australia
1 shared publication
Latest Publications
- Open Access
- 19 October 2026
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
Prolonged low-level inter-human mpox transmission in Nigeria prior to the global outbreak in 2022: a mathematical modelling study
Background: The 2022 global mpox outbreak was linked to clade IIb viruses that previously circulated in Nigeria. Genomic evidence suggests that, in Nigeria, sustained human-to-human transmission may have begun as early as 2016. Methods: Using a stochastic branching process model, we investigated the conditions under which mpox could have persisted at low levels in Nigeria between 2016 and April 2022 without triggering a clearly recognized outbreak and quantified the potential hidden burden of infection and international exportation. Results: We found that when R is close to 1 and secondary infections show low variability (low heterogeneity, i.e. no superspreading), sustained but slow transmission can persist with non-negligible probability. Under our baseline modelling assumptions (R = 1.0, Poisson offspring distribution), 9% of simulations resulted in cryptic epidemics that lasted throughout the study period. Conditional on a trajectory being classified as cryptic under this scenario, the average epidemic size was 8500 infections (95% prediction interval: 2900–17 000) per cryptic epidemic, compared with 241 confirmed cases reported. This implies substantial under-ascertainment with a detection rate of 2.8% (95% prediction interval: 1.4–8.3%). Estimated exportations to Europe and North America were consistent with the small number of documented travel-associated cases before 2022. Conclusions: These findings support the plausibility of prolonged, low-level mpox transmission in Nigeria prior to the recognized global outbreak.
- 19 October 2026
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
Open AccessProlonged low-level inter-human mpox transmission in Nigeria prior to the global outbreak in 2022: a mathematical modelling study
Background: The 2022 global mpox outbreak was linked to clade IIb viruses that previously circulated in Nigeria. Genomic evidence suggests that, in Nigeria, sustained human-to-human transmission may have begun as early as 2016. Methods: Using a stochastic branching process model, we investigated the conditions under which mpox could have persisted at low levels in Nigeria between 2016 and April 2022 without triggering a clearly recognized outbreak and quantified the potential hidden burden of infection and international exportation. Results: We found that when R is close to 1 and secondary infections show low variability (low heterogeneity, i.e. no superspreading), sustained but slow transmission can persist with non-negligible probability. Under our baseline modelling assumptions (R = 1.0, Poisson offspring distribution), 9% of simulations resulted in cryptic epidemics that lasted throughout the study period. Conditional on a trajectory being classified as cryptic under this scenario, the average epidemic size was 8500 infections (95% prediction interval: 2900–17 000) per cryptic epidemic, compared with 241 confirmed cases reported. This implies substantial under-ascertainment with a detection rate of 2.8% (95% prediction interval: 1.4–8.3%). Estimated exportations to Europe and North America were consistent with the small number of documented travel-associated cases before 2022. Conclusions: These findings support the plausibility of prolonged, low-level mpox transmission in Nigeria prior to the recognized global outbreak.
- Open Access
- 19 October 2026
- Published by Springer Nature in Nature Communications
Short-term effectiveness and impact of Vaxchora vaccine during the 2024 cholera outbreak in Mayotte
Global cholera resurgence and vaccine shortage have driven the adoption of reactive one-dose strategies with killed oral cholera vaccines (OCVs). The live-attenuated vaccine CVD 103-HgR (Vaxchora) shows high efficacy in human challenge studies, but its real-world effectiveness in outbreaks is unknown. Here, we analyze the 2024 outbreak in Mayotte, focusing on Koungou village, which had high cholera incidence and vaccine uptake. We develop several stochastic models and calibrate them to daily cases by vaccination status. In total, 3354 individuals (71%) of Koungou’s at-risk population ( n = 4733) received CVD 103-HgR, and 77 cases were confirmed, with symptom onset between 19 April and 7 July 2024. At baseline, we estimate a basic reproduction number $${R}_{0}$$ of 1.5 (95% credible interval (CrI): 1.2, 1.9) and a CVD 103-HgR effectiveness in preventing cholera of 87% (95% CrI: 74, 99), remaining between 75% and 91% across scenarios. Counterfactual simulations estimate 536 (95% CrI: 240, 824) cases averted at baseline, with a range of point estimates from 152 to 1228 across sensitivity analyses. Rapid single-dose CVD 103-HgR deployment is associated with high effectiveness during a real‑world outbreak, with a substantial but more uncertain population impact, supporting the inclusion of live-attenuated OCVs in reactive strategies when necessary.- 19 October 2026
- Published by Springer Nature in Nature Communications
Open AccessShort-term effectiveness and impact of Vaxchora vaccine during the 2024 cholera outbreak in Mayotte
Global cholera resurgence and vaccine shortage have driven the adoption of reactive one-dose strategies with killed oral cholera vaccines (OCVs). The live-attenuated vaccine CVD 103-HgR (Vaxchora) shows high efficacy in human challenge studies, but its real-world effectiveness in outbreaks is unknown. Here, we analyze the 2024 outbreak in Mayotte, focusing on Koungou village, which had high cholera incidence and vaccine uptake. We develop several stochastic models and calibrate them to daily cases by vaccination status. In total, 3354 individuals (71%) of Koungou’s at-risk population ( n = 4733) received CVD 103-HgR, and 77 cases were confirmed, with symptom onset between 19 April and 7 July 2024. At baseline, we estimate a basic reproduction number $${R}_{0}$$ of 1.5 (95% credible interval (CrI): 1.2, 1.9) and a CVD 103-HgR effectiveness in preventing cholera of 87% (95% CrI: 74, 99), remaining between 75% and 91% across scenarios. Counterfactual simulations estimate 536 (95% CrI: 240, 824) cases averted at baseline, with a range of point estimates from 152 to 1228 across sensitivity analyses. Rapid single-dose CVD 103-HgR deployment is associated with high effectiveness during a real‑world outbreak, with a substantial but more uncertain population impact, supporting the inclusion of live-attenuated OCVs in reactive strategies when necessary. - Open Access
- 27 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Mobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling
Accurately capturing time-varying human behavior remains a major challenge for real-time epidemic modeling and response. During the COVID-19 pandemic, synthetic contact matrices derived from mobility and behavioral data emerged as a scalable alternative to empirical contact surveys, yet their comparative performance remained unclear. Here, we systematically evaluate synthetic and empirical age-stratified contact matrices in France from March 2020 to May 2022, comparing contact patterns and their ability to reproduce observed epidemic dynamics. While both sources captured similar temporal trends in contacts, empirical matrices recorded 3.4 times more contacts for individuals under 19 than synthetic matrices during school-open periods. The model parameterized with synthetic matrices provided the best fit to hospital admissions and best captured hospitalization patterns for adolescents, adults, and seniors, whereas deviations remained for children across both models. Neither matrix allowed models to fully reproduce serological trends in children, highlighting the challenges both approaches face in capturing their disease-relevant contacts. The weekly update of synthetic matrices enabled smoother reconstructions of hospitalization trends during transitional phases, while empirical matrices required strong assumptions between survey waves. These findings support synthetic matrices as a reliable, flexible, cost-effective operational tool for real-time epidemic modeling, and highlight the need for routine collection of age-stratified mobility data to improve pandemic response.
- 27 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessMobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling
Accurately capturing time-varying human behavior remains a major challenge for real-time epidemic modeling and response. During the COVID-19 pandemic, synthetic contact matrices derived from mobility and behavioral data emerged as a scalable alternative to empirical contact surveys, yet their comparative performance remained unclear. Here, we systematically evaluate synthetic and empirical age-stratified contact matrices in France from March 2020 to May 2022, comparing contact patterns and their ability to reproduce observed epidemic dynamics. While both sources captured similar temporal trends in contacts, empirical matrices recorded 3.4 times more contacts for individuals under 19 than synthetic matrices during school-open periods. The model parameterized with synthetic matrices provided the best fit to hospital admissions and best captured hospitalization patterns for adolescents, adults, and seniors, whereas deviations remained for children across both models. Neither matrix allowed models to fully reproduce serological trends in children, highlighting the challenges both approaches face in capturing their disease-relevant contacts. The weekly update of synthetic matrices enabled smoother reconstructions of hospitalization trends during transitional phases, while empirical matrices required strong assumptions between survey waves. These findings support synthetic matrices as a reliable, flexible, cost-effective operational tool for real-time epidemic modeling, and highlight the need for routine collection of age-stratified mobility data to improve pandemic response.
- Open Access
Mobility-driven synthetic contact matrices: a scalable solution for real-time pandemic response modeling
Accurately capturing time-varying human behavior remains a major challenge for real-time epidemic modeling and response. During the COVID-19 pandemic, synthetic contact matrices derived from mobility and behavioral data emerged as a scalable alternative to empirical contact surveys, yet their comparative performance remained unclear. Here, we systematically evaluate synthetic and empirical age-stratified contact matrices in France from March 2020 to May 2022, comparing contact patterns and their ability to reproduce observed epidemic dynamics. While both sources captured similar temporal trends in contacts, empirical matrices recorded 3.4 times more contacts for individuals under 19 than synthetic matrices during school-open periods. The model parameterized with synthetic matrices provided the best fit to hospital admissions and best captured hospitalization patterns for adolescents, adults, and seniors, whereas deviations remained for children across both models. Neither matrix allowed models to fully reproduce serological trends in children, highlighting the challenges both approaches face in capturing their disease-relevant contacts. The weekly update of synthetic matrices enabled smoother reconstructions of hospitalization trends during transitional phases, while empirical matrices required strong assumptions between survey waves. These findings support synthetic matrices as a reliable, flexible, cost-effective operational tool for real-time epidemic modeling, and highlight the need of routine collection of age-stratified mobility data to improve pandemic response.
Open AccessMobility-driven synthetic contact matrices: a scalable solution for real-time pandemic response modeling
Accurately capturing time-varying human behavior remains a major challenge for real-time epidemic modeling and response. During the COVID-19 pandemic, synthetic contact matrices derived from mobility and behavioral data emerged as a scalable alternative to empirical contact surveys, yet their comparative performance remained unclear. Here, we systematically evaluate synthetic and empirical age-stratified contact matrices in France from March 2020 to May 2022, comparing contact patterns and their ability to reproduce observed epidemic dynamics. While both sources captured similar temporal trends in contacts, empirical matrices recorded 3.4 times more contacts for individuals under 19 than synthetic matrices during school-open periods. The model parameterized with synthetic matrices provided the best fit to hospital admissions and best captured hospitalization patterns for adolescents, adults, and seniors, whereas deviations remained for children across both models. Neither matrix allowed models to fully reproduce serological trends in children, highlighting the challenges both approaches face in capturing their disease-relevant contacts. The weekly update of synthetic matrices enabled smoother reconstructions of hospitalization trends during transitional phases, while empirical matrices required strong assumptions between survey waves. These findings support synthetic matrices as a reliable, flexible, cost-effective operational tool for real-time epidemic modeling, and highlight the need of routine collection of age-stratified mobility data to improve pandemic response.
- Open Access
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 381 (6655) , 336-343
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) now arise in the context of heterogeneous human connectivity and population immunity. Through a large-scale phylodynamic analysis of 115,622 Omicron BA.1 genomes, we identified >6,000 introductions of the antigenically distinct VOC into England and analyzed their local transmission and dispersal history. We find that six of the eight largest English Omicron lineages were already transmitting when Omicron was first reported in southern Africa (22 November 2021). Multiple datasets show that importation of Omicron continued despite subsequent restrictions on travel from southern Africa as a result of export from well-connected secondary locations. Initiation and dispersal of Omicron transmission lineages in England was a two-stage process that can be explained by models of the country’s human geography and hierarchical travel network. Our results enable a comparison of the processes that drive the invasion of Omicron and other VOCs across multiple spatial scales.
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 381 (6655) , 336-343
Open AccessGenomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) now arise in the context of heterogeneous human connectivity and population immunity. Through a large-scale phylodynamic analysis of 115,622 Omicron BA.1 genomes, we identified >6,000 introductions of the antigenically distinct VOC into England and analyzed their local transmission and dispersal history. We find that six of the eight largest English Omicron lineages were already transmitting when Omicron was first reported in southern Africa (22 November 2021). Multiple datasets show that importation of Omicron continued despite subsequent restrictions on travel from southern Africa as a result of export from well-connected secondary locations. Initiation and dispersal of Omicron transmission lineages in England was a two-stage process that can be explained by models of the country’s human geography and hierarchical travel network. Our results enable a comparison of the processes that drive the invasion of Omicron and other VOCs across multiple spatial scales.
- Open Access
- 14 November 2022
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 30, 100634
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna
- 14 November 2022
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 30, 100634
Open AccessModelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna
- 17 November 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (48) , 30118-30125
Heterogeneity in social and epidemiological factors determines the risk of measles outbreaks
Significance: The recent increase in large-scale migration trends generates several concerns about public health in destination countries, especially in the presence of massive incoming human flows from countries with a disrupted healthcare system. Here, we analyze the flow of 3.5 M Syrian refugees toward Turkey to quantify the risk of measles outbreaks. Our results suggest that heterogeneity in immunity, population distribution, and human-mobility flows is mostly responsible for such a risk: In fact, adequate policies of social integration and vaccine campaigns provide the most effective strategies to reduce measles disease risks for both migrant and hosting populations.
- 17 November 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (48) , 30118-30125
Heterogeneity in social and epidemiological factors determines the risk of measles outbreaks
Significance: The recent increase in large-scale migration trends generates several concerns about public health in destination countries, especially in the presence of massive incoming human flows from countries with a disrupted healthcare system. Here, we analyze the flow of 3.5 M Syrian refugees toward Turkey to quantify the risk of measles outbreaks. Our results suggest that heterogeneity in immunity, population distribution, and human-mobility flows is mostly responsible for such a risk: In fact, adequate policies of social integration and vaccine campaigns provide the most effective strategies to reduce measles disease risks for both migrant and hosting populations.